STOCK TITAN

Cue Health Inc. - HLTH STOCK NEWS

Welcome to our dedicated page for Cue Health news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health stock.

Cue Health Inc. (HLTH) delivers innovative at-home diagnostic solutions through its integrated platform of molecular testing and mobile health technology. This news hub provides investors and stakeholders with essential updates about the company’s financial performance, product developments, and strategic initiatives.

Access timely announcements including quarterly earnings reports, FDA clearances, partnership agreements, and research breakthroughs. Our curated collection ensures you stay informed about HLTH’s advancements in digital health diagnostics without speculative commentary.

Key updates cover regulatory milestones, new test kit approvals, executive leadership changes, and scientific validation studies. Each release maintains focus on verifiable facts about the company’s patented technology and market position.

Bookmark this page for direct access to primary source materials about Cue Health’s progress in transforming personal health monitoring. Check regularly for objective updates on their mobile-integrated diagnostic ecosystem and business developments.

Rhea-AI Summary

Cue Health (Nasdaq: HLTH), a healthcare technology company, has filed for Chapter 7 bankruptcy in the District of Delaware, aiming to wind down its business. Despite efforts to reduce costs and find additional financing or strategic transactions, the Board of Directors, after thorough review and consultation, determined that filing for Chapter 7 was in the best interest of stakeholders. A bankruptcy trustee will be appointed to manage the liquidation of assets to pay creditors. Cue Health expressed gratitude to its employees, customers, and vendors for their contributions and partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-39.51%
Tags
none
-
Rhea-AI Summary

Cue Health (Nasdaq: HLTH) has received a warning letter from the FDA regarding its Emergency Use Authorized (EUA) COVID-19 test. The healthcare technology company is currently evaluating the letter and determining an appropriate response. Further details will be provided in the coming days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.94%
Tags
-
Rhea-AI Summary

Cue Health Inc. (HLTH) is set to release its first quarter 2024 financial results on May 13, 2024, without hosting a conference call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.85%
Tags
Rhea-AI Summary
Cue Health Inc. (HLTH) appoints Clint Sever as CEO and adds Dr. Paul Brown and Dr. Lisa Danzig as strategic advisors to enhance business operations and commercialization efforts. The company aims to review its business strategy and cost structure for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.44%
Tags
none
-
Rhea-AI Summary
Cue Health Inc. reports $18.8 million in Q4 revenue and $70.9 million in full-year 2023 revenue. The company submitted clinical data for RSV and Flu A/B tests to the FDA. Cue is in late-stage development of Herpes + Mpox Multiplex Molecular Test. They executed cost reduction plans saving $200 million annually. Fourth quarter revenue breakdown shows private sector revenue at $17.0 million and public sector revenue at $1.8 million. Cue reported a GAAP net loss of $148.4 million in Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.14%
Tags
-
Rhea-AI Summary
Cue Health Inc. (HLTH) will announce its Q4 and full-year 2023 financial results on March 13, 2024. The company will host a conference call and webcast to discuss the results and recent highlights. Participants can register in advance for the call and access it via telephone or webinar.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.9%
Tags
Rhea-AI Summary
Cue Health (HLTH) partners with Tarsadia Investments and appoints Rishi Reddy to its Board of Directors. The company aims to enhance shareholder value and improve operational efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
management
-
Rhea-AI Summary
Cue Health, a healthcare technology company (Nasdaq: HLTH), will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
conferences
-
Rhea-AI Summary
HLTH - Cue Health Inc. Reports Impressive Q3 2023 Financial Results, Revenue Exceeds Expectations, Plans for New Multiplex Molecular Test Development, and Achieves Cost Savings. Revenue of $17.5 million, 50% above guidance range. Three tests in review with the FDA. Annualized run rate cost savings of approximately $165 million. Net change in cash for the quarter was $(17.1) million. Ended the third quarter with cash and cash equivalents of $111.5 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
Rhea-AI Summary
Cue Health Inc. will release its Q3 2023 financial results on November 8, 2023. A conference call and webcast will be held to discuss the results and recent highlights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
Cue Health Inc.

Nasdaq:HLTH

HLTH Rankings

HLTH Stock Data

6.90M
159.09M
11.57%
52.81%
0.49%
Health Information Services
Laboratory Analytical Instruments
Link
United States
SAN DIEGO